Annual report pursuant to Section 13 and 15(d)

EQUITY METHOD INVESTMENTS (Details)

v2.4.0.6
EQUITY METHOD INVESTMENTS (Details) (USD $)
In Millions, unless otherwise specified
 12 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2011
Other Equity Method Investees [Member]
Dec. 31, 2010
Other Equity Method Investees [Member]
Dec. 31, 2009
Other Equity Method Investees [Member]
Oct. 01, 2010
Coca-Cola Enterprises Inc.
Dec. 31, 2009
Coca-Cola Enterprises Inc.
Dec. 31, 2011
Other Equity Method Investments
Dec. 31, 2010
Other Equity Method Investments
Dec. 31, 2009
Other Equity Method Investments
Dec. 31, 2011
Coca-Cola Hellenic
Dec. 31, 2011
Coca-Cola FEMSA
Dec. 31, 2011
Coca-Cola Amatil
Dec. 31, 2011
Acquisition of Coca Cola Enterprises North American Business [Member]
Dec. 31, 2010
Acquisition of Coca Cola Enterprises North American Business [Member]
Equity method investments, disclosures                              
Business Acquisition Cost of Acquired Entity Percentage of Indirect Ownership Interest Transfer           33.00%                  
Equity Method Investment, Summarized Financial Information, Current Assets     $ 13,960 $ 12,223                      
Ownership interest in Equity investee (as a percent)                     23.00% 29.00% 29.00%    
Summarized financial information - Income statement                              
Net operating revenues     42,472 38,663 34,292 16,464 21,645                
Cost of goods sold     26,271 23,053 20,205 10,028 13,333                
Gross profit     16,201 15,610 14,087 6,436 8,312                
Operating income (loss)     4,181 4,134 3,657 1,369 1,527                
Consolidated net income (loss)     2,237 2,659 2,269                    
Less: Net income (loss) attributable to noncontrolling interests     99 89 78                    
Net income (loss) attributable to common shareowners     2,138 2,570 2,191 677 731                
Summary of significant transactions with CCE                              
Concentrate, syrup and finished product sales to CCE           4,737 6,032 6,900 6,200 5,600          
Syrup and finished product purchases from CCE           263 351 430 205 152          
CCE purchases of sweeteners through our Company           251 419                
Marketing payments made by us directly to CCE           314 415 1,147 1,034 878          
Marketing payments made to third parties on behalf of CCE           106 174                
Local media and marketing program reimbursements from CCE           268 330                
Payments made to CCE for dispensing equipment repair services           64 87                
Other payments - net           19 66                
Charge related to preexisting relationships                           1 265
Investment in equity method investees in excess of the proportionate share of net assets 1,575                            
Equity Method Investment, Summarized Financial Information, Noncurrent Assets     27,152 26,524                      
Equity Method Investment, Summarized Financial Information, Assets     41,112 38,747                      
Equity Method Investment, Summarized Financial Information, Current Liabilities     10,545 9,039                      
Equity Method Investment, Summarized Financial Information, Noncurrent Liabilities     11,646 11,175                      
Equity Method Investment, Summarized Financial Information, Liabilities     22,191 20,214                      
Equity Method Investment, Summarized Financial Information, Equity or Capital     18,392 18,046                      
Equity Method Investment, Summarized Financial Information, Noncontrolling Interest     529 487                      
Equity Method Investment Summarized Financial Information, Equity     18,921 18,533                      
EQUITY METHOD INVESTMENTS $ 7,233 $ 6,954 $ 7,234 $ 6,954